サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1234343

動物用ワクチンの世界市場：分析・実績・予測 (2018年～2029年)

Global Veterinary Vaccine Market Report, History and Forecast 2018-2029
出版日: | 発行: QYResearch | ページ情報: 英文 169 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
動物用ワクチンの世界市場：分析・実績・予測 (2018年～2029年)
出版日: 2023年03月10日
発行: QYResearch
ページ情報: 英文 169 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用ワクチンの市場規模は、COVID-19パンデミックとロシア・ウクライナ戦争の影響により、2022年に108億600万米ドルと評価され、2029年までに172億6,000万米ドルの改訂規模に達する見通しで、予測期間中 (2023年～2029年) に6.94%のCAGRで成長すると予測されています。

北米の動物用ワクチンの市場規模は、2022年に38億7,000万米ドルに達した後、予測期間中 (2023年～2029年) に6.29%のCAGRで成長し、2029年までに59億800万米ドルに達すると予測されています。

アジア太平洋の動物用ワクチンの市場規模は、2022年に32億4,000万米ドルに達した後、予測期間中 (2023年～2029年) に7.98%のCAGRで成長し、2029年までに55億6,500万米ドルに達する見込みです。

欧州の動物用ワクチンの市場規模は、2022年に24億2,600万米ドルに達した後、予測期間中 (2023年～2029年) に6.3%のCAGRで成長し、2029年までに37億800万米ドルに達すると予想されます。

当レポートでは、世界の動物用ワクチンの市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2018年～2029年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 動物用ワクチン：市場概要

  • 動物用ワクチン：製品概要
  • 動物用ワクチン市場：種類別
    • 弱毒生ワクチン
    • 不活化ワクチン
  • 種類別の市場規模
    • 市場規模の概要：種類別 (2018年～2029年)
    • 過去の市場規模：種類別 (2018年～2023年)
    • 市場規模の予測：種類別 (2024年～2029年)
  • 主要地域の市場規模：種類別
    • 北米の動物用ワクチンの販売：種類別 (2018年～2023年)
    • 欧州の動物用ワクチンの販売：種類別 (2018年～2023年)
    • アジア太平洋の動物用ワクチンの販売：種類別 (2018年～2023年)
    • 南米の動物用ワクチンの販売：種類別 (2018年～2023年)
    • 中東・アフリカの動物用ワクチンの販売：種類別 (2018年～2023年)

第2章 動物用ワクチン：企業別の市場競争

  • 世界の動物用ワクチンの主要企業の販売 (2018年～2023年)
  • 世界の動物用ワクチンの主要企業の収益 (2018年～2023年)
  • 世界の動物用ワクチンの主要企業の価格 (2018年～2023年)
  • 世界の動物用ワクチンの主要メーカーの製造拠点・販売エリア・製品種類
  • 動物用ワクチン市場の競争状況と動向
  • 世界の主要メーカー：企業の種類別 (ティア1、ティア2、ティア3) (収益別、2022年)
  • 主要メーカーの設立時期
  • 主要メーカーの主力製品
  • 企業合併・買収 (M&A)、拡大

第3章 動物用ワクチン：地域別の現状と展望

  • 世界の動物用ワクチンの市場規模・CAGR：地域別 (2018年・2022年・2029年)
  • 過去の市場規模：地域別
  • 市場規模の予測：地域別

第4章 動物用ワクチン：用途別

  • 動物用ワクチン市場：用途別
    • 家畜
    • コンパニオンアニマル
  • 用途別の市場規模
    • 市場規模の概要：用途別 (2018年～2029年)
    • 過去の市場規模：用途別 (2018年～2023年)
    • 市場規模の予測：用途別 (2024年～2029年)
  • 主要地域の市場規模：用途別
    • 北米の動物用ワクチンの販売：用途別 (2018年～2023年)
    • 欧州の動物用ワクチンの販売：用途別 (2018年～2023年)
    • アジア太平洋の動物用ワクチンの販売：用途別 (2018年～2023年)
    • 南米の動物用ワクチンの販売：用途別 (2018年～2023年)
    • 中東・アフリカの動物用ワクチンの販売：用途別 (2018年～2023年)

第5章 北米の動物用ワクチン：国別

  • 過去の市場規模：国別
  • 市場規模の予測：国別

第6章 欧州の動物用ワクチン：国別

第7章 アジア太平洋の動物用ワクチン：地域別

第8章 南米の動物用ワクチン：国別

第9章 中東・アフリカの動物用ワクチン：国別

第10章 企業プロファイル

  • Merck
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • CAHIC
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • WINSUN
  • Elanco
  • Virbac
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • CAVAC
  • Kyoto Biken Laboratories
  • FATRO
  • Vaksindo
  • Bio-Labs
  • Avimex Animal Health
  • MEVAC
  • Biovac
  • Atafen
  • Dyntec
  • RVSRI
  • Medion

第11章 上流工程・機会・課題・リスク・影響要因の分析

  • 動物用ワクチンの主要原材料
  • 製造コストの構造
  • 動物用ワクチンの産業チェーンの分析
  • 動物用ワクチンの市場力学

第12章 マーケティング戦略分析、流通業者

  • 販売チャンネル
  • 動物用ワクチンの流通業者
  • 動物用ワクチンの下流工程の顧客

第13章 調査結果と結論

第14章 付録

図表

List of Tables

  • Table 1. Global Veterinary Vaccine Sales by Type: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Global Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
  • Table 3. Global Veterinary Vaccine Sales Market Share in Volume by Type (2018-2023)
  • Table 4. Global Veterinary Vaccine Sales by Type (2018-2023) & (US$ Million)
  • Table 5. Global Veterinary Vaccine Sales Market Share in Value by Type (2018-2023)
  • Table 6. Global Veterinary Vaccine Price by Type (2018-2023) & (USD/K Doses)
  • Table 7. Global Veterinary Vaccine Sales by Type (2024-2029) & (M Doses)
  • Table 8. Global Veterinary Vaccine Sales Market Share in Volume by Type (2024-2029)
  • Table 9. Global Veterinary Vaccine Sales by Type (2024-2029) & (US$ Million)
  • Table 10. Global Veterinary Vaccine Sales Market Share in Value by Type (2024-2029)
  • Table 11. Global Veterinary Vaccine Price by Type (2024-2029) & (USD/K Doses)
  • Table 12. North America Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
  • Table 13. North America Veterinary Vaccine Sales by Type (2018-2023) & (US$ Million)
  • Table 14. Europe Veterinary Vaccine Sales (M Doses) by Type (2018-2023)
  • Table 15. Europe Veterinary Vaccine Sales by Type (2018-2023) & (US$ Million)
  • Table 16. Asia-Pacific Veterinary Vaccine Sales (M Doses) by Type (2018-2023)
  • Table 17. Asia-Pacific Veterinary Vaccine Sales by Type (2018-2023) & (US$ Million)
  • Table 18. South America Veterinary Vaccine Sales (M Doses) by Type (2018-2023)
  • Table 19. South America Veterinary Vaccine Sales by Type (2018-2023) & (US$ Million)
  • Table 20. Middle East and Africa Veterinary Vaccine Sales (M Doses) by Type (2018-2023)
  • Table 21. Middle East and Africa Veterinary Vaccine Sales by Type (2018-2023) & (US$ Million)
  • Table 22. Global Veterinary Vaccine Sales by Company (2019-2023) & (M Doses)
  • Table 23. Global Veterinary Vaccine Sales Share by Company (2019-2023)
  • Table 24. Global Veterinary Vaccine Revenue by Company (2019-2023) & (US$ Million)
  • Table 25. Global Veterinary Vaccine Revenue Share by Company (2019-2023)
  • Table 26. Global Market Veterinary Vaccine Price by Company (2019-2023) & (USD/K Doses)
  • Table 27. Global Veterinary Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
  • Table 28. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 29. Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2022)
  • Table 30. Founded Date of Key Veterinary Vaccine Manufacturers
  • Table 31. Key Manufacturers Veterinary Vaccine Product Type
  • Table 32. Mergers & Acquisitions, Expansion Plans
  • Table 33. Global Veterinary Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 34. Global Veterinary Vaccine Sales by Region (2018-2023) & (M Doses)
  • Table 35. Global Veterinary Vaccine Sales Market Share in Volume by Region (2018-2023)
  • Table 36. Global Veterinary Vaccine Sales by Region (2018-2023) & (US$ Million)
  • Table 37. Global Veterinary Vaccine Sales Market Share in Value by Region (2018-2023)
  • Table 38. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
  • Table 39. Global Veterinary Vaccine Sales by Region (2024-2029) & (M Doses)
  • Table 40. Global Veterinary Vaccine Sales Market Share in Volume by Region (2024-2029)
  • Table 41. Global Veterinary Vaccine Sales by Region (2024-2029) & (US$ Million)
  • Table 42. Global Veterinary Vaccine Sales Market Share in Value by Region (2024-2029)
  • Table 43. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2024-2029)
  • Table 44. Global Veterinary Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 45. Global Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
  • Table 46. Global Veterinary Vaccine Sales Market Share in Volume by Application (2018-2023)
  • Table 47. Global Veterinary Vaccine Sales by Application (2018-2023) & (US$ Million)
  • Table 48. Global Veterinary Vaccine Sales Market Share in Value by Application (2018-2023)
  • Table 49. Global Veterinary Vaccine Price by Application (2018-2023) & (USD/K Doses)
  • Table 50. Global Veterinary Vaccine Sales by Application (2024-2029) & (M Doses)
  • Table 51. Global Veterinary Vaccine Sales Market Share in Volume by Application (2024-2029)
  • Table 52. Global Veterinary Vaccine Sales by Application (2024-2029) & (US$ Million)
  • Table 53. Global Veterinary Vaccine Sales Market Share in Value by Application (2024-2029)
  • Table 54. Global Veterinary Vaccine Price by Application (2024-2029) & (USD/K Doses)
  • Table 55. North America Veterinary Vaccine Sales by Application (2018-2023) & (US$ Million)
  • Table 56. Europe Veterinary Vaccine Sales by Application (2018-2023) & (US$ Million)
  • Table 57. Asia-Pacific Veterinary Vaccine Sales by Application (2018-2023) & (US$ Million)
  • Table 58. South America Veterinary Vaccine Sales by Application (2018-2023) & (US$ Million)
  • Table 59. Middle East and Africa Veterinary Vaccine Sales by Application (2018-2023) & (US$ Million)
  • Table 60. North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 61. North America Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
  • Table 62. North America Veterinary Vaccine Sales Market Share in Volume by Country (2018-2023)
  • Table 63. North America Veterinary Vaccine Sales by Country (2018-2023) & (US$ Million)
  • Table 64. North America Veterinary Vaccine Sales Market Share in Value by Country (2018-2023)
  • Table 65. North America Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
  • Table 66. North America Veterinary Vaccine Sales Market Share in Volume by Country (2024-2029)
  • Table 67. North America Veterinary Vaccine Sales by Country (2024-2029) & (US$ Million)
  • Table 68. North America Veterinary Vaccine Sales Market Share in Value by Country (2024-2029)
  • Table 69. Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 70. Europe Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
  • Table 71. Europe Veterinary Vaccine Sales Market Share in Volume by Country (2018-2023)
  • Table 72. Europe Veterinary Vaccine Sales by Country (2018-2023) & (US$ Million)
  • Table 73. Europe Veterinary Vaccine Sales Market Share in Value by Country (2018-2023)
  • Table 74. Europe Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
  • Table 75. Europe Veterinary Vaccine Sales Market Share in Volume by Country (2024-2029)
  • Table 76. Europe Veterinary Vaccine Sales by Country (2024-2029) & (US$ Million)
  • Table 77. Europe Veterinary Vaccine Sales Market Share in Value by Country (2024-2029)
  • Table 78. Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 79. Asia-Pacific Veterinary Vaccine Sales by Region (2018-2023) & (M Doses)
  • Table 80. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Region (2018-2023)
  • Table 81. Asia-Pacific Veterinary Vaccine Sales by Region (2018-2023) & (US$ Million)
  • Table 82. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Region (2018-2023)
  • Table 83. Asia-Pacific Veterinary Vaccine Sales by Region (2024-2029) & (M Doses)
  • Table 84. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Region (2024-2029)
  • Table 85. Asia-Pacific Veterinary Vaccine Sales by Region (2024-2029) & (US$ Million)
  • Table 86. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Region (2024-2029)
  • Table 87. South America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 88. South America Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
  • Table 89. South America Veterinary Vaccine Sales Market Share in Volume by Country (2018-2023)
  • Table 90. South America Veterinary Vaccine Sales by Country (2018-2023) & (US$ Million)
  • Table 91. South America Veterinary Vaccine Sales Market Share in Value by Country (2018-2023)
  • Table 92. South America Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
  • Table 93. South America Veterinary Vaccine Sales Market Share in Volume by Country (2024-2029)
  • Table 94. South America Veterinary Vaccine Sales by Country (2024-2029) & (US$ Million)
  • Table 95. South America Veterinary Vaccine Sales Market Share in Value by Country (2024-2029)
  • Table 96. Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 97. Middle East and Africa Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
  • Table 98. Middle East and Africa Veterinary Vaccine Sales Market Share in Volume by Country (2018-2023)
  • Table 99. Middle East and Africa Veterinary Vaccine Sales by Country (2018-2023) & (US$ Million)
  • Table 100. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Country (2018-2023)
  • Table 101. Middle East and Africa Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
  • Table 102. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2024-2029)
  • Table 103. Middle East and Africa Veterinary Vaccine Sales by Country (2024-2029) & (US$ Million)
  • Table 104. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Country (2024-2029)
  • Table 105. Merck Company Profile
  • Table 106. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Merck 2019-2023
  • Table 107. Zoetis Company Profile
  • Table 108. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Zoetis 2019-2023
  • Table 109. Boehringer Ingelheim Company Profile
  • Table 110. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2019-2023
  • Table 111. Ceva Company Profile
  • Table 112. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Ceva 2019-2023
  • Table 113. CAHIC Company Profile
  • Table 114. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of CAHIC 2019-2023
  • Table 115. HVRI Company Profile
  • Table 116. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of HVRI 2019-2023
  • Table 117. Ringpu Biology Company Profile
  • Table 118. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Ringpu Biology 2019-2023
  • Table 119. Yebio Company Profile
  • Table 120. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Yebio 2019-2023
  • Table 121. DHN Company Profile
  • Table 122. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of DHN 2019-2023
  • Table 123. WINSUN Company Profile
  • Table 124. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of WINSUN 2019-2023
  • Table 125. Elanco Company Profile
  • Table 126. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Elanco 2019-2023
  • Table 127. Virbac Company Profile
  • Table 128. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Virbac 2019-2023
  • Table 129. Jinyu Bio-Technology Company Profile
  • Table 130. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Jinyu Bio-Technology 2019-2023
  • Table 131. ChengDu Tecbond Company Profile
  • Table 132. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of ChengDu Tecbond 2019-2023
  • Table 133. CAVAC Company Profile
  • Table 134. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of CAVAC 2019-2023
  • Table 135. Kyoto Biken Laboratories Company Profile
  • Table 136. Veterinary Vaccine Product Picture of Kyoto Biken Laboratories
  • Table 137. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Kyoto Biken Laboratories 2019-2023
  • Table 138. FATRO Company Profile
  • Table 139. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of FATRO 2019-2023
  • Table 140. Vaksindo Company Profile
  • Table 141. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Vaksindo 2019-2023
  • Table 142. Bio-Labs Company Profile
  • Table 143. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Bio-Labs 2019-2023
  • Table 144. Avimex Animal Health Company Profile
  • Table 145. Veterinary Vaccine Product Picture of Avimex Animal Health
  • Table 146. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Avimex Animal Health 2019-2023
  • Table 147. MEVAC Company Profile
  • Table 148. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of MEVAC 2019-2023
  • Table 149. Biovac Company Profile
  • Table 150. Veterinary Vaccine Product Picture of Biovac
  • Table 151. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Biovac 2019-2023
  • Table 152. Atafen Company Profile
  • Table 153. Veterinary Vaccine Product Picture of Atafen
  • Table 154. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Atafen 2019-2023
  • Table 155. Dyntec Company Profile
  • Table 156. Veterinary Vaccine Product Picture of Dyntec
  • Table 157. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Dyntec 2019-2023
  • Table 158. RVSRI Company Profile
  • Table 159. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of RVSRI 2019-2023
  • Table 160. Medion Company Profile
  • Table 161. Veterinary Vaccine Product Picture of Medion
  • Table 162. Veterinary Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (M USD) and Gross Margin of Medion 2019-2023
  • Table 163. Key Raw Materials Lists
  • Table 164. Raw Materials Key Suppliers Lists
  • Table 165. Veterinary Vaccine Market Trends
  • Table 166. Veterinary Vaccine Market Drivers
  • Table 167. Veterinary Vaccine Market Challenges
  • Table 168. Veterinary Vaccine Market Restraints
  • Table 169. Veterinary Vaccine Distributors List
  • Table 170. Veterinary Vaccine Downstream Customers
  • Table 171. Research Programs/Design for This Report
  • Table 172. Key Data Information from Secondary Sources
  • Table 173. Key Data Information from Primary Sources
  • Table 174. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Veterinary Vaccine Product Picture
  • Figure 2. Global Veterinary Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Veterinary Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
  • Figure 4. Global Veterinary Vaccine Sales Status and Outlook (2018-2029) & (M Doses)
  • Figure 5. Product Picture of Live Attenuated Vaccines
  • Figure 6. Global Live Attenuated Vaccines Sales YoY Growth (2018-2029) & (M Doses)
  • Figure 7. Product Picture of Inactivated Vaccines
  • Figure 8. Global Inactivated Vaccines Sales YoY Growth (2018-2029) & (M Doses)
  • Figure 9. Global Veterinary Vaccine Sales by Type (2018-2029) & (US$ Million)
  • Figure 10. Global Veterinary Vaccine Market Share by Type in 2022
  • Figure 11. Global Veterinary Vaccine Market Share by Type in 2029
  • Figure 12. North America Veterinary Vaccine Sales Market Share in Volume by Type in 2022
  • Figure 13. North America Veterinary Vaccine Sales Market Share in Value by Type in 2022
  • Figure 14. Europe Veterinary Vaccine Sales Market Share in Volume by Type in 2022
  • Figure 15. Europe Veterinary Vaccine Sales Market Share in Value by Type in 2022
  • Figure 16. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Type in 2022
  • Figure 17. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Type in 2022
  • Figure 18. South America Veterinary Vaccine Sales Market Share in Volume by Type in 2022
  • Figure 19. South America Veterinary Vaccine Sales Market Share in Value by Type in 2022
  • Figure 20. Middle East and Africa Veterinary Vaccine Sales Market Share in Volume by Type in 2022
  • Figure 21. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Type in 2022
  • Figure 22. The 5 Largest Manufacturers in the World: Market Share by Veterinary Vaccine Revenue in 2022
  • Figure 23. The 10 Largest Manufacturers in the World: Market Share by Veterinary Vaccine Revenue in 2022
  • Figure 24. Product Picture of Farm Animal
  • Figure 25. Global Farm Animal Sales YoY Growth (2018-2029) & (M Doses)
  • Figure 26. Product Picture of Companion Animal
  • Figure 27. Global Companion Animal Sales YoY Growth (2018-2029) & (M Doses)
  • Figure 28. Global Veterinary Vaccine Sales by Application (2018-2029) & (US$ Million)
  • Figure 29. Global Veterinary Vaccine Market Share by Application in 2022
  • Figure 30. Global Veterinary Vaccine Market Share by Application in 2029
  • Figure 31. North America Veterinary Vaccine Sales Market Share in Value by Application in 2022
  • Figure 32. Europe Veterinary Vaccine Sales Market Share in Value by Application in 2022
  • Figure 33. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Application in 2022
  • Figure 34. South America Veterinary Vaccine Sales Market Share in Value by Application in 2022
  • Figure 35. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Application in 2022
  • Figure 36. Veterinary Vaccine Product Picture of Merck
  • Figure 37. Veterinary Vaccine Product Picture of Zoetis
  • Figure 38. Veterinary Vaccine Product Picture of Boehringer Ingelheim
  • Figure 39. Veterinary Vaccine Product Picture of Ceva
  • Figure 40. Veterinary Vaccine Product Picture of CAHIC
  • Figure 41. Veterinary Vaccine Product Picture of HVRI
  • Figure 42. Veterinary Vaccine Product Picture of Ringpu Biology
  • Figure 43. Veterinary Vaccine Product Picture of Yebio
  • Figure 44. Veterinary Vaccine Product Picture of DHN
  • Figure 45. Veterinary Vaccine Product Picture of WINSUN
  • Figure 46. Veterinary Vaccine Product Picture of Elanco
  • Figure 47. Veterinary Vaccine Product Picture of Virbac
  • Figure 48. Veterinary Vaccine Product Picture of Jinyu Bio-Technology
  • Figure 49. Veterinary Vaccine Product Picture of ChengDu Tecbond
  • Figure 50. Veterinary Vaccine Product Picture of CAVAC
  • Figure 51. Veterinary Vaccine Product Picture of FATRO
  • Figure 52. Veterinary Vaccine Product Picture of Vaksindo
  • Figure 53. Veterinary Vaccine Product Picture of Bio-Labs
  • Figure 54. Veterinary Vaccine Product Picture of MEVAC
  • Figure 55. Veterinary Vaccine Manufacturing Cost Structure
  • Figure 56. Veterinary Vaccine Industrial Chain Analysis
  • Figure 57. Channels of Distribution
  • Figure 58. Distributors Profiles
  • Figure 59. Bottom-up and Top-down Approaches for This Report
  • Figure 60. Data Triangulation
  • Figure 61. Key Executives Interviewed
目次

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Veterinary Vaccine was estimated at US$ 10806 million in the year 2022, is projected to reach a revised size of US$ 17260 million by 2029, growing at a CAGR of 6.94% during the forecast period 2023-2029.

North American market for Veterinary Vaccine was valued at $ 3870 million in 2022, will reach $ 5908 million by 2029, at a CAGR of 6.29 % during the forecast period of 2023 through 2029.

Asia-Pacific market for Veterinary Vaccine was valued at $ 3240 million in 2022, will reach $ 5565 million by 2029, at a CAGR of 7.98 % during the forecast period of 2023 through 2029.

Europe market for Veterinary Vaccine was valued at $ 2426 million in 2022, will reach $ 3708 million by 2029, at a CAGR of 6.3 % during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.

The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Veterinary Vaccine segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

  • Merck
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • CAHIC
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • WINSUN
  • Elanco
  • Virbac
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • CAVAC
  • Kyoto Biken Laboratories
  • FATRO
  • Vaksindo
  • Bio-Labs
  • Avimex Animal Health
  • MEVAC
  • Biovac
  • Atafen
  • Dyntec
  • RVSRI
  • Medion

Segment by Type

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Others

Segment by Application

  • Farm Animal
  • Companion Animal

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • Egypt
    • South Africa

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

1 Veterinary Vaccine Market Overview

  • 1.1 Veterinary Vaccine Product Overview
  • 1.2 Veterinary Vaccine Market by Type
    • 1.2.1 Live Attenuated Vaccines
    • 1.2.2 Inactivated Vaccines
  • 1.3 Global Veterinary Vaccine Market Size by Type
    • 1.3.1 Global Veterinary Vaccine Market Size Overview by Type (2018-2029)
    • 1.3.2 Global Veterinary Vaccine Historic Market Size Review by Type (2018-2023)
    • 1.3.3 Global Veterinary Vaccine Forecasted Market Size by Type (2024-2029)
  • 1.4 Key Regions Market Size by Type
    • 1.4.1 North America Veterinary Vaccine Sales Breakdown by Type (2018-2023)
    • 1.4.2 Europe Veterinary Vaccine Sales Breakdown by Type (2018-2023)
    • 1.4.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Type (2018-2023)
    • 1.4.4 South America Veterinary Vaccine Sales Breakdown by Type (2018-2023)
    • 1.4.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Type (2018-2023)

2 Veterinary Vaccine Market Competition by Company

  • 2.1 Global Top Players by Veterinary Vaccine Sales (2018-2023)
  • 2.2 Global Top Players by Veterinary Vaccine Revenue (2019-2023)
  • 2.3 Global Top Players by Veterinary Vaccine Price (2019-2023)
  • 2.4 Global Top Manufacturers Veterinary Vaccine Manufacturing Base Distribution, Sales Area, Product Type
  • 2.5 Veterinary Vaccine Market Competitive Situation and Trends
    • 2.5.1 Veterinary Vaccine Market Concentration Rate (2019-2023)
    • 2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Revenue in 2022
  • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2022)
  • 2.7 Founded Date of Key Veterinary Vaccine Manufacturers
  • 2.8 Key Manufacturers Veterinary Vaccine Product Offered
  • 2.9 Mergers & Acquisitions, Expansion

3 Veterinary Vaccine Status and Outlook by Region

  • 3.1 Global Veterinary Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
  • 3.2 Global Veterinary Vaccine Historic Market Size by Region
    • 3.2.1 Global Veterinary Vaccine Sales in Volume by Region (2018-2023)
    • 3.2.2 Global Veterinary Vaccine Sales in Value by Region (2018-2023)
    • 3.2.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2018-2023)
  • 3.3 Global Veterinary Vaccine Forecasted Market Size by Region
    • 3.3.1 Global Veterinary Vaccine Sales in Volume by Region (2024-2029)
    • 3.3.2 Global Veterinary Vaccine Sales in Value by Region (2024-2029)
    • 3.3.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Veterinary Vaccine by Application

  • 4.1 Veterinary Vaccine Market by Application
    • 4.1.1 Farm Animal
    • 4.1.2 Companion Animal
  • 4.2 Global Veterinary Vaccine Market Size by Application
    • 4.2.1 Global Veterinary Vaccine Market Size Overview by Application (2018-2029)
    • 4.2.2 Global Veterinary Vaccine Historic Market Size Review by Application (2018-2023)
    • 4.2.3 Global Veterinary Vaccine Forecasted Market Size by Application (2024-2029)
  • 4.3 Key Regions Market Size by Application
    • 4.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2018-2023)
    • 4.3.2 Europe Veterinary Vaccine Sales Breakdown by Application (2018-2023)
    • 4.3.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Application (2018-2023)
    • 4.3.4 South America Veterinary Vaccine Sales Breakdown by Application (2018-2023)
    • 4.3.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Application (2018-2023)

5 North America Veterinary Vaccine by Country

  • 5.1 North America Veterinary Vaccine Historic Market Size by Country
    • 5.1.1 North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 5.1.2 North America Veterinary Vaccine Sales in Volume by Country (2018-2023)
    • 5.1.3 North America Veterinary Vaccine Sales in Value by Country (2018-2023)
  • 5.2 North America Veterinary Vaccine Forecasted Market Size by Country
    • 5.2.1 North America Veterinary Vaccine Sales in Volume by Country (2024-2029)
    • 5.2.2 North America Veterinary Vaccine Sales in Value by Country (2024-2029)

6 Europe Veterinary Vaccine by Country

  • 6.1 Europe Veterinary Vaccine Historic Market Size by Country
    • 6.1.1 Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 6.1.2 Europe Veterinary Vaccine Sales in Volume by Country (2018-2023)
    • 6.1.3 Europe Veterinary Vaccine Sales in Value by Country (2018-2023)
  • 6.2 Europe Veterinary Vaccine Forecasted Market Size by Country
    • 6.2.1 Europe Veterinary Vaccine Sales in Volume by Country (2024-2029)
    • 6.2.2 Europe Veterinary Vaccine Sales in Value by Country (2024-2029)

7 Asia-Pacific Veterinary Vaccine by Region

  • 7.1 Asia-Pacific Veterinary Vaccine Historic Market Size by Region
    • 7.1.1 Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
    • 7.1.2 Asia-Pacific Veterinary Vaccine Sales in Volume by Region (2018-2023)
    • 7.1.3 Asia-Pacific Veterinary Vaccine Sales in Value by Region (2018-2023)
  • 7.2 Asia-Pacific Veterinary Vaccine Forecasted Market Size by Region
    • 7.2.1 Asia-Pacific Veterinary Vaccine Sales in Volume by Region (2024-2029)
    • 7.2.2 Asia-Pacific Veterinary Vaccine Sales in Value by Region (2024-2029)

8 South America Veterinary Vaccine by Country

  • 8.1 South America Veterinary Vaccine Historic Market Size by Country
    • 8.1.1 South America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 8.1.2 South America Veterinary Vaccine Sales in Volume by Country (2018-2023)
    • 8.1.3 South America Veterinary Vaccine Sales in Value by Country (2018-2023)
  • 8.2 South America Veterinary Vaccine Forecasted Market Size by Country
    • 8.2.1 South America Veterinary Vaccine Sales in Volume by Country (2024-2029)
    • 8.2.2 South America Veterinary Vaccine Sales in Value by Country (2024-2029)

9 Middle East and Africa Veterinary Vaccine by Country

  • 9.1 Middle East and Africa Veterinary Vaccine Historic Market Size by Country
    • 9.1.1 Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 9.1.2 Middle East and Africa Veterinary Vaccine Sales in Volume by Country (2018-2023)
    • 9.1.3 Middle East and Africa Veterinary Vaccine Sales in Value by Country (2018-2023)
  • 9.2 Middle East and Africa Veterinary Vaccine Forecasted Market Size by Country
    • 9.2.1 Middle East and Africa Veterinary Vaccine Sales in Volume by Country (2024-2029)
    • 9.2.2 Middle East and Africa Veterinary Vaccine Sales in Value by Country (2024-2029)

10 Company Profiles

  • 10.1 Merck
    • 10.1.1 Company Profile
    • 10.1.2 Product Information
    • 10.1.3 Sales, Price and Revenue
  • 10.2 Zoetis
    • 10.2.1 Company Profile
    • 10.2.2 Product Information
    • 10.2.3 Sales, Price and Revenue
  • 10.3 Boehringer Ingelheim
    • 10.3.1 Company Profile
    • 10.3.2 Product Information
    • 10.3.3 Sales, Price and Revenue
  • 10.4 Ceva
    • 10.4.1 Company Profile
    • 10.4.2 Product Information
    • 10.4.3 Sales, Price and Revenue
  • 10.5 CAHIC
    • 10.5.1 Company Profile
    • 10.5.2 Product Information
    • 10.5.3 Sales, Price and Revenue
  • 10.6 HVRI
    • 10.6.1 Company Profile
    • 10.6.2 Product Information
    • 10.6.3 Sales, Price and Revenue
  • 10.7 Ringpu Biology
    • 10.7.1 Company Profile
    • 10.7.2 Product Information
    • 10.7.3 Sales, Price and Revenue
  • 10.8 Yebio
    • 10.8.1 Company Profile
    • 10.8.2 Product Information
    • 10.8.3 Sales, Price and Revenue
  • 10.9 DHN
    • 10.9.1 Company Profile
    • 10.9.2 Product Information
    • 10.9.3 Sales, Price and Revenue
  • 10.10 WINSUN
    • 10.10.1 Company Profile
    • 10.10.2 Product Information
    • 10.10.3 Sales, Price and Revenue
  • 10.11 Elanco
    • 10.11.1 Company Profile
    • 10.11.2 Product Information
    • 10.11.3 Sales, Price and Revenue
  • 10.12 Virbac
    • 10.12.1 Company Profile
    • 10.12.2 Product Information
    • 10.12.3 Sales, Price and Revenue
  • 10.13 Jinyu Bio-Technology
    • 10.13.1 Company Profile
    • 10.13.2 Product Information
    • 10.13.3 Sales, Price and Revenue
  • 10.14 ChengDu Tecbond
    • 10.14.1 Company Profile
    • 10.14.2 Product Information
    • 10.14.3 Sales, Price and Revenue
  • 10.15 CAVAC
    • 10.15.1 Company Profile
    • 10.15.2 Product Information
    • 10.15.3 Sales, Price and Revenue
  • 10.16 Kyoto Biken Laboratories
    • 10.16.1 Company Profile
    • 10.16.2 Product Information
    • 10.16.3 Sales, Price and Revenue
  • 10.17 FATRO
    • 10.17.1 Company Profile
    • 10.17.2 Product Information
    • 10.17.3 Sales, Price and Revenue
  • 10.18 Vaksindo
    • 10.18.1 Company Profile
    • 10.18.2 Product Information
    • 10.18.3 Sales, Price and Revenue
  • 10.19 Bio-Labs
    • 10.19.1 Company Profile
    • 10.19.2 Product Information
    • 10.19.3 Sales, Price and Revenue
  • 10.20 Avimex Animal Health
    • 10.20.1 Company Profile
    • 10.20.2 Product Information
    • 10.20.3 Sales, Price and Revenue
  • 10.21 MEVAC
    • 10.21.1 Company Profile
    • 10.21.2 Product Information
    • 10.21.3 Sales, Price and Revenue
  • 10.22 Biovac
    • 10.22.1 Company Profile
    • 10.22.2 Product Information
    • 10.22.3 Sales, Price and Revenue
  • 10.23 Atafen
    • 10.23.1 Company Profile
    • 10.23.2 Product Information
    • 10.23.3 Sales, Price and Revenue
  • 10.24 Dyntec
    • 10.24.1 Company Profile
    • 10.24.2 Product Information
    • 10.24.3 Sales, Price and Revenue
  • 10.25 RVSRI
    • 10.25.1 Company Profile
    • 10.25.2 Product Information
    • 10.25.3 Sales, Price and Revenue
  • 10.26 Medion
    • 10.26.1 Company Profile
    • 10.26.2 Product Information
    • 10.26.3 Sales, Price and Revenue

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

  • 11.1 Veterinary Vaccine Key Raw Materials
    • 11.1.1 Key Raw Materials
    • 11.1.2 Raw Materials Key Suppliers
  • 11.2 Manufacturing Cost Structure
    • 11.2.1 Raw Materials
    • 11.2.2 Labor Cost
    • 11.2.3 Manufacturing Expenses
  • 11.3 Veterinary Vaccine Industrial Chain Analysis
  • 11.4 Veterinary Vaccine Market Dynamics
    • 11.4.1 Veterinary Vaccine Industry Trends
    • 11.4.2 Veterinary Vaccine Market Drivers
    • 11.4.3 Veterinary Vaccine Market Challenges
    • 11.4.4 Veterinary Vaccine Market Restraints

12 Marketing Strategy Analysis, Distributors

  • 12.1 Sales Channel
  • 12.2 Veterinary Vaccine Distributors
  • 12.3 Veterinary Vaccine Downstream Customers

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer